Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
10,647,547
-
Total 13F shares
-
844,510
-
Share change
-
-75,076
-
Total reported value
-
$2,043,750
-
Price per share
-
$2.42
-
Number of holders
-
17
-
Value change
-
-$4,406
-
Number of buys
-
10
-
Number of sells
-
5
Institutional Holders of Neuraxis, INC - Common Stock, par value $0.001 per share (NRXS) as of Q2 2025
As of 30 Jun 2025,
Neuraxis, INC - Common Stock, par value $0.001 per share (NRXS) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
844,510 shares.
The largest 10 holders included
AIGH Capital Management LLC, Apis Capital Advisors, LLC, PARSONS CAPITAL MANAGEMENT INC/RI, Manatuck Hill Partners, LLC, VANGUARD GROUP INC, STIFEL FINANCIAL CORP, CITADEL ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, Wealthcare Advisory Partners LLC, and Royal Bank of Canada.
This page lists
17
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.